Picture of Covalon Technologies logo

COV Covalon Technologies Cashflow Statement

0.000.00%
ca flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Annual cashflow statement for Covalon Technologies, fiscal year end - September 30th, CAD millions except per share, conversion factor applied.

2021
September 30th
2022
September 30th
2023
September 30th
2024
September 30th
2025
September 30th
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line0.419-9.25-4.462.672.06
Depreciation
Amortisation
Non-Cash Items27.20.99920.10.487
Discontinued Operations
Unusual Items
Other Non-Cash Items
Changes in Working Capital-1.08-0.083-0.318-0.283-1.21
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities27.2-7.31-1.813.472.29
Capital Expenditures-0.178-1.08-1.32-0.417-0.847
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-0.1010.239-0.1350.1350
Sale of Fixed Assets
Other Investing Cash Flow
Cash from Investing Activities-0.279-0.843-1.45-0.282-0.847
Financing Cash Flow Items-0.29300.2140.185
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-8.25-2.19-2.164.97-0.529
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash19.4-8.89-5.277.950.621